Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin L Sos

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Cell Cycle (Georgetown, Tex.)|October 22, 2009
Systematically linking drug susceptibility to cancer genome aberrationsMartin L Sos, Roman K Thomas
Oncogene|October 16, 2020
The next tier of EGFR resistance mutations in lung cancerHannah L Tumbrink, Alena Heimsoeth, Martin L Sos
Nature|November 22, 2013
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactionsJonathan M Ostrem, Ulf Peters, Martin L Sos, et al.
Cell Cycle (Georgetown, Tex.)|July 25, 2017
Family matters: How MYC family oncogenes impact small cell lung cancerJohannes Brägelmann, Stefanie Böhm, Matthew R Guthrie, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2008
Expression of signaling mediators downstream of EGF-receptor predict sensitivity to small molecule inhibitors directed against the EGF-receptor pathwayMartin L Sos, Thomas Zander, Roman K Thomas, et al.
Bioorganic & Medicinal Chemistry|December 7, 2010
Synthesis and biological evaluation of 7-substituted-1-(3-bromophenylamino)isoquinoline-4-carbonitriles as inhibitors of myosin light chain kinase and epidermal growth factor receptorHaridas B Rode, Martin L Sos, Christian Grütter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2015
Squamous cell lung cancer: from tumor genomics to cancer therapeuticsDavid R Gandara, Peter S Hammerman, Martin L Sos, et al.
Journal of the American Chemical Society|November 1, 2013
Staurosporine-derived inhibitors broaden the scope of analog-sensitive kinase technologyMichael S Lopez, Jonathan W Choy, Ulf Peters, et al.
Cell|August 20, 2013
A neo-substrate that amplifies catalytic activity of parkinson's-disease-related kinase PINK1Nicholas T Hertz, Amandine Berthet, Martin L Sos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignanciesRoman K Thomas, Martin L Sos, Thomas Zander, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Cell Cycle (Georgetown, Tex.)|October 22, 2009
Systematically linking drug susceptibility to cancer genome aberrationsMartin L Sos, Roman K Thomas
Oncogene|October 16, 2020
The next tier of EGFR resistance mutations in lung cancerHannah L Tumbrink, Alena Heimsoeth, Martin L Sos
Nature|November 22, 2013
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactionsJonathan M Ostrem, Ulf Peters, Martin L Sos, et al.
Cell Cycle (Georgetown, Tex.)|July 25, 2017
Family matters: How MYC family oncogenes impact small cell lung cancerJohannes Brägelmann, Stefanie Böhm, Matthew R Guthrie, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2008
Expression of signaling mediators downstream of EGF-receptor predict sensitivity to small molecule inhibitors directed against the EGF-receptor pathwayMartin L Sos, Thomas Zander, Roman K Thomas, et al.
Bioorganic & Medicinal Chemistry|December 7, 2010
Synthesis and biological evaluation of 7-substituted-1-(3-bromophenylamino)isoquinoline-4-carbonitriles as inhibitors of myosin light chain kinase and epidermal growth factor receptorHaridas B Rode, Martin L Sos, Christian Grütter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2015
Squamous cell lung cancer: from tumor genomics to cancer therapeuticsDavid R Gandara, Peter S Hammerman, Martin L Sos, et al.
Journal of the American Chemical Society|November 1, 2013
Staurosporine-derived inhibitors broaden the scope of analog-sensitive kinase technologyMichael S Lopez, Jonathan W Choy, Ulf Peters, et al.
Cell|August 20, 2013
A neo-substrate that amplifies catalytic activity of parkinson's-disease-related kinase PINK1Nicholas T Hertz, Amandine Berthet, Martin L Sos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignanciesRoman K Thomas, Martin L Sos, Thomas Zander, et al.
Pageof 6